ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

Biotechnology

ARTBIO

ARTBIO's headquarters in Cambridge, United States

The Basel office focuses on quality assurance, supply chain management, and executive leadership for global operations.

People (6)

Jobs (0)

Other offices